[1] 王秋梅,赵庆,黄仕明,等. 早期肠内营养与肠外营养在预防肝性脑病患者应激性溃疡出血和感染的疗效对比分析. 中华医院感染学杂志,2016,26(22):5138-5140. [2] 陈东风,孙文静. 肝性脑病的新认识-从指南到临床. 实用肝脏病杂志,2016,19(1):16-19. [3] 王军,张流,熊华刚,等. 醒脑静联合纳洛酮治疗肝性脑病患者认知和血清炎症因子水平变化. 实用肝脏病杂志,2018,21(3): 471-472. [4] Mekky MA,Riad AR,Gaber MA,et al.Rifaximin versus metronidazole in management of acute episode of hepatic encephalopathy:An open labeled randomized clinical trial. Arab J Gastroenterol,2018,19(2):76-79. [5] Bajaj JS,Barbara G,DuPont HL,et al. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive disease. Dig Liver Dis,2018,50(8):741-749. [6] Kornerup LS,Gluud LL,Vilstrup H,et al.Update on the therapeutic management of hepatic encephalopathy. Curr Gastroenterol Rep,2018,20(5):21. [7] Kinny-Koster B,Bartels M,Becker S.Plasma amino acid concentrations predict mortality in patients with end-stage liver disease. PLoS One,2016,11(7):0159205. [8] 孙晓. 微生态制剂联合肠内营养治疗肝性脑病患者营养学及血清指标的变化. 实用肝脏病杂志,2017,20(6):777-778. [9] Flamm SL. Covert hepatic encephalopathy:who should be tested and treated Clin Liver Dis,2015,19(3):473-485. [10] Henderson PK,Herrera JL.Should we treat minimal/covert hepatic encephalopathy,and with what Clin Liver Dis,2015,19(3):487-495. [11] Oikonomou T,Papatheodoridis GV,Samarkos M.Clinical impact of microbiome in patients with decompensated cirrhosis. World J Gastroenterol,2018,24(34):3813-3820. [12] Puri P,Thursz M.Intensive enteral nutrition in alcoholic hepatitis:more food for thought. Gastroenterology,2016,150(4):803-805. [13] Marlicz W,Wunsch E,Mydlowska M,et al.The effect of short term treatment with probiotic VSL#3 on various clinical and biochemical parameters in patients with liver cirrhosis.J Physiol Pharmacol,2016,67(6):867-877. [14] Sharma BC,Singh J.Probiotics in management of hepatic encephalopathy. Metab Brain Dis,2016,31(6):1295-1301. [15] Saab S,Suraweera D,Au J,et al.Probiotics are helpful in hepatic encephalopathy:a Meta-analysis of randomized trials. Liver Int,2016,36(7):986-993. [16] Je IG,Lee DG,Jeong DG.The probiotic,id-jpl934,attenuates dextran sulfate sodium-induced colitis in mice through inhibition of proinflammatory cytokines expression. J Med Food,2018,21(9):858-865. |